Postdoc, MSc PhD
Institut of Clinical Medicine - Hematology
carirose@rm.dk 

My name is Carina. I work as postdoc in HemeLab, hold a PhD from the Faculty of Health from Aarhus University and is a graduate of Biology also from Aarhus University. I have a fundamental interest in flow cytometry and in HemeLab I have implemented the imaging flow cytometry methodology and strive to demonstrate the diagnostic potential of the technique in the complex field of hematology.
I lead our projects on how imaging flow cytometry can be used to rethink diagnostics in myelodysplastic syndrome and acute myeloid leukemia by employing morphometric evaluation of neoplastic cells.

Postdoc, MSc PhD
Institut of Clinical Medicine - Hematology
mariem@rm.dk

I have a PhD-degree from Health, Aarhus University. With a background in Molecular Medicine my work focuses on transformation of follicular lymphoma. This event is analyzed through molecular biological methods and clinicopathological data, including proteomics, immunohistochemistry and more. In addition, I enjoy supervising students in our group and getting involved in their projects as well.

MD, Ph.d.-student
Institut of Clinical Medicine - Hematology
maja.aner@auh.rm.dk 

My name is Maja. I am a medical doctor specializing in hematology from Aarhus University. Since 2013, I have been part of the lymphoma research group, studying the microenvironment in Hodgkin lymphoma. I began my PhD-study in 2020, and have been using various molecular methods, such as proteomics, immunohistochemistry, and gene expression analyses to try to better understand the mechanism behind the disease. In addition to my research, I also mentor and supervise students in our group.

Ph.d.-student
Institut of Clinical Medicine - Hematology
johasr@rm.dk 

I have a background as a medical doctor from Aarhus University. My PhD project addresses acute myeloid leukemia (AML), focusing on in vivo delivery of CRISPR-Cas9 using lipid nanoparticles as a candidate vector.  The long-term scope of the project is novel therapy for patients with AML.

Ph.d.-student
Institut of Clinical Medicine - Hematology
kawolt@rm.dk

My name is Katharina, and I have a Master’s degree in Molecular Medicine from Aarhus University. I started my PhD in March 2024. I am working on developing a novel gene therapy for fusion-driven childhood acute leukemia using CRISPR-Cas9. 

Ph.d.-student
Institut of Clinical Medicine - Hematology
trihyb@rm.dk 

My name is Trine. I am a PhD student in HemeLab and have a Master’s degree in molecular medicine from Aarhus University. My project focuses on evaluating dysplasia in myeloid hematological malignancies using a combination of artificial intelligence and imaging flow cytometry. So far, I have focused on assessing the applicability of this technique to distinguish healthy and leukemic stem cells from acute myeloid leukemia patients. In addition, I am also involved in research concerning lymphoma in immunosuppressed patients, which has included various analyses such as immunohistochemistry and next-generation sequencing.

Master's student
Molecular Biology
sebrei@rm.dk 

My name is Sebastian. I am a MSc student in Molecular Biology at Aarhus University. Cancer research has always been my main interest, so I am thrilled to be involved in applied research projects with fusion-cancers in focus here at HemeLab. My current project is to investigate whether our CRISPR gene therapy technique can be utilized in fusion-sarcomas. More specifically synovial sarcoma which is characterized by translocation t(18;X). I have previously been involved in the acute myeloid leukemia with translocation t(8;21) project with Johannes Frasez Sørensen here in HemeLab. Besides working with in vivo CRISPR/Cas9 delivery in the AML project, I have also previously worked with delivery optimization of the Cas9 protein.

Master's student
Molecular Biology
melahn@rm.dk 

My name is Melanie. I am a MSc student in Molecular Biology at Aarhus University. I joined the lab in September 2024 and I am currently working on a project concerning a specific type of acute myeloid leukemia with the translocation t(8;21). The lab has previously shown with a proof-of-concept study that the translocation can be removed by gene editing therapy using CRISPR/Cas9 technology. My role in this project is to characterize cellular changes following gene therapy by utilizing transcriptomic and proteomics methods.

Master's student
Molecular Medicine
daiane@rm.dk 

My name is Daniel, and I have been a part of this group since August 2024. I am a Master’s student in Molecular Medicine currently working on my Master Thesis. The project is focused on treating Acute Myeloid Leukemia with genetic knockout of a driving fusion-gene. Specifically, my work will be focused on optimizing Lipid Nanoparticles, as a CRISPR delivery vector, to specifically target the HSPCs giving rise to AML.

Master's student
Molecular Biology
fanhan@rm.dk 

My name is Fanny, and I am currently doing an MSc in Molecular Biology at Aarhus University. I joined the lab in September 2024, where I am working on a project focused on acute myeloid leukemia (AML) with the t(8;21) translocation. The lab has previously demonstrated, through a proof-of-concept study, that this translocation can be targeted and removed using CRISPR/Cas9-based gene editing. My role in the project involves further evaluating the CRISPR/Cas9 therapy in cell cultures, patient samples, and mouse models.

Master's student
Molecular Medicine
somour@rm.dk 

My name is Sofie, and I am a MSc student in Molecular Medicine at Aarhus University. I joined the lab in February 2024 and am currently conducting my master’s thesis, which focuses on in vivo delivery of CRISPR-Cas9 using lipid nanoparticles as a delivery vector. This project aims to develop targeted gene-editing therapies for acute myeloid leukemia (AML) patients with the t(8;21) translocation, with the goal of establishing this as a novel therapy for AML.

Master's student
Molecular Medicine
nalore@rm.dk 

My name is Naja, and I am a MSc student in Molecular Medicine at Aarhus University, currently conducting my master’s thesis in HemeLab. My project focuses on using Imaging Flow cytometry (IFC) to identify dysgranulopoiesis in patients with myelodysplastic syndrome (MDS). The long-term goal is to improve MDS diagnostics by integrating IFC and AI-driven image classification for detection of dysplasia.

Master's student
Molecular Medicine
caromj@rm.dk 

My name is Caroline, and I am pursuing a Master’s degree in Molecular Medicine at Aarhus University. My project focuses on follicular lymphoma (FL), where I investigate protein biomarkers linked to early disease progression (POD24). Through proteomics analysis and bioinformatics, I aim to identify key markers that can improve early risk assessment. Significant findings will be validated using immunohistochemistry to enhance clinical relevance.

Master's student
Molecular Medicine
frejln@rm.dk 

My name is Freja, and I am currently doing a MSc in Molecular Medicine at Aarhus University. I joined the lab in January 2025 where I am working on a project focusing on in vivo delivery of CRISPR-Cas9 using lipid nanoparticles as delivery vectors. This project aims to develop targeted gene-editing therapies for acute myeloid leukemia (AML) patients with the t(8;21) translocation, with the goal of establishing this as a novel therapy for AML.

Master's student
Molecular Medicine
cecdoh@rm.dk 

My name is Cecilie, and I am currently studying a Master of Molecular Medicine at Aarhus University. My project is focused on the characterization of follicular lymphoma patients. My long-term goal is to contribute to a greater understanding of the molecular events behind the histological transformation of these patients and identify biomarkers for patient-specific risk stratification. To achieve this goal variable techniques including immunohistochemistry, imaging mass cytometry, etc. will be applied.

Master's student
Molecular Medicine
sigsci@rm.dk 

My name is Signe, and I am pursuing a degree in Molecular Medicine at Aarhus University. I am currently working on a research project aiming to enhance the diagnosis of myelodysplastic syndrome (MDS). My work focuses on utilizing Imaging Flow cytometry (IFC) to identify dysgranulopoiesis in MDS patients, with the goal of integrating IFC into diagnostic protocols to improve the detection of granulocyte dysplasia. Following this project, I will begin my master’s thesis in the fall of 2025.

Master's student
Molecular Medicine
nikaru@rm.dk 

My name is Nithiyaa, and I study Molecular Medicine at Aarhus University. In February 2025, I joined the laboratory to conduct my Molecular Medicine Research Project. My research focuses on gene therapy targeting the t(9;11) translocation associated with acute myeloid leukemia (AML). This approach uses CRISPR-Cas9-based gene editing, where electroporation and lipid nanoparticles are employed to deliver Cas9 and guide RNA to leukemia cell lines.

MSc Molecular Medicine
Institut of Clinical Medicine - Hematology
mayapd@rm.dk

My name is Maya. I am a molecular medicine master student, and I have a bachelor's degree in molecular medicine from Aarhus University. I joined Ludvigsen Lab in spring 2023, and during the spring I will be working on a research project investigating blood cells in the bone marrow. My project focuses on the megakaryopoiesis, and I will be using imaging flow cytometry to establish an assay and gating templates, which can be used to detect abnormally developed and matured megakaryocytes in bone marrow from patients with myelodysplastic syndrome (MDS).